196 Followers on Owler

Helsinn

is a Switzerland-based biopharmaceutical firm that researches and develops novel therapies for the treatment of cancer and rare diseases...

Read more

Helsinn

is a Switzerland-based biopharmaceutical firm that researches and develops novel therapies for the treatment of cancer and rare diseases...

Read more
Download

Helsinn News

Helsinn Press Releases

Helsinn Headquarters

Via Pian Scairolo 9

Pazzallo-Lugano, Ticino6912

Driving Directions »

Helsinn Summary

ABOUT

Overview

Helsinn is a Switzerland-based biopharmaceutical firm that researches and develops novel therapies for the treatment of cancer and rare diseases. Helsinn was founded in 1976. Helsinn's headquarters is located in Pazzallo-Lugano, Ticino, CH 6912. Hels...

CEO

Helsinn's CEO, Melanie Rolli, currently has an approval rating of 82%. Helsinn's primary competitors are Adaptimmune, Artios, Redx Pharma and 22 more.

Acquisitions

There have been no acquisitions found related to Helsinn

Frequently Asked Questions about Helsinn

  1. When was Helsinn founded?

    Helsinn was founded in 1976
  2. Who is Helsinn's CEO?

    Helsinn's CEO is Melanie Rolli
  3. How much revenue does Helsinn generate?

    Helsinn generates $57.8M in revenue
  4. How much funding does Helsinn have?

    Helsinn has historically raised $0 in funding
  5. Where is Helsinn's headquarters?

    Helsinn's headquarters is in Pazzallo-Lugano Ticino, CH
  1. How many employees does Helsinn have?

    Helsinn has 680 employees
  2. What sector does Helsinn operate in?

    Helsinn is in Pharmaceuticals, Biotechnology
  3. Who are Helsinn's competitors?

    Helsinn's top competitors are Adaptimmune, Artios, Redx Pharma
  4. Who has Helsinn invested in?

    Helsinn's has invested in companies such as On Target Laboratories, Thorne

Trending Companies